Cargando…

Efficacy of Bifidobacterium bifidum G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study

Chronic constipation is a functional disorder that decreases a patient’s quality of life (QOL). Because dysbiosis has been associated with constipation, we aimed to investigate the efficacy of Bifidobacterium bifidum G9-1 (BBG9-1) in improving QOL in patients with constipation. This was a prospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	FUYUKI, Akiko, HIGURASHI, Takuma, KESSOKU, Takaomi, ASHIKARI, Keiichi, YOSHIHARA, Tsutomu, MISAWA, Noboru, IWAKI, Michihiro, KOBAYASHI, Takashi, OHKUBO, Hidenori, YONEDA, Masato, USUDA, Haruki, WADA, Koichiro, NAKAJIMA, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMFH Press 2021
Materias:	Full Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099630/ https://www.ncbi.nlm.nih.gov/pubmed/33996367 http://dx.doi.org/10.12938/bmfh.2020-073

Ejemplares similares

The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin
por: Yoshihara, Tsutomu, et al.
Publicado: (2020)

A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours
por: Yoshihara, Tsutomu, et al.
Publicado: (2021)

Exploratory, multicenter, open-label study to evaluate the effects of linaclotide in patients with chronic constipation with an insufficient response to magnesium oxide: A study protocol
por: Yoshihara, Tsutomu, et al.
Publicado: (2022)

Prior appendectomy and cerebral infarction as potential risk factors for recurrent ischemic colitis: A retrospective observational study
por: Takatsu, Tomohiro, et al.
Publicado: (2023)

Difference in Defecation Desire Between Patients With and Without Chronic Constipation: A Large-Scale Internet Survey
por: Ohkubo, Hidenori, et al.
Publicado: (2020)

The efficacy of aspirin and metformin combination therapy in patients with rectal aberrant crypt foci: a double-blinded randomized controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2020)

The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial
por: Higurashi, Takuma, et al.
Publicado: (2020)

Natural History of Chronic Intestinal Pseudo-obstruction and Need for Palliative Care
por: Tanaka, Kosuke, et al.
Publicado: (2023)

Elobixibat Effectively Relieves Chronic Constipation in Patients with Cancer Regardless of the Amount of Food Intake
por: Ozaki, Anna, et al.
Publicado: (2021)

Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipation
por: Yamamoto, Atsushi, et al.
Publicado: (2022)

Gastrointestinal Cancer Stage at Diagnosis Before and During the COVID-19 Pandemic in Japan
por: Kuzuu, Kento, et al.
Publicado: (2021)

Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled Trial
por: Ozaki, Anna, et al.
Publicado: (2022)

Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipation
por: Tanaka, Kosuke, et al.
Publicado: (2022)

Continued Use of a Single Antiplatelet Agent Does Not Increase the Risk of Delayed Bleeding After Colorectal Endoscopic Submucosal Dissection
por: Arimoto, Jun, et al.
Publicado: (2017)

Comparing the effectiveness of magnesium oxide and naldemedine in preventing opioid-induced constipation: a proof of concept, single institutional, two arm, open-label, phase II, randomized controlled trial: the MAGNET study
por: Ozaki, Anna, et al.
Publicado: (2020)

Lubiprostone improves intestinal permeability in humans, a novel therapy for the leaky gut: A prospective randomized pilot study in healthy volunteers
por: Kato, Takayuki, et al.
Publicado: (2017)

Safety Evaluations of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI
por: Kim, Min Jeong, et al.
Publicado: (2018)

The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Investigation of the Local Recurrence Rate after Colorectal Endoscopic Mucosal Resection: Is Incomplete Polyp Resection Really a Clinically Important Problem? Analysis of the Rationale for the “Resect and Discard” Strategy
por: Arimoto, Jun, et al.
Publicado: (2019)

Strengthening of the intestinal epithelial tight junction by Bifidobacterium bifidum
por: Hsieh, Chen-Yu, et al.
Publicado: (2015)

Effects of Bifidobacterium bifidum in Mice Infected with Citrobacter rodentium
por: Wen, Bijun, et al.
Publicado: (2019)

Bifidobacterium bifidum as an example of a specialized human gut commensal
por: Turroni, Francesca, et al.
Publicado: (2014)

Exploring Amino Acid Auxotrophy in Bifidobacterium bifidum PRL2010
por: Ferrario, Chiara, et al.
Publicado: (2015)

Factors affecting viability of Bifidobacterium bifidum during spray drying
por: Shokri, Zahra, et al.
Publicado: (2015)

Bifidobacterium bifidum-Mediated Specific Delivery of Nanoparticles for Tumor Therapy
por: Tang, Yu, et al.
Publicado: (2021)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

Changes in the Number of Gastrointestinal Cancers and Stage at Diagnosis with COVID-19 Pandemic in Japan: A Multicenter Cohort Study
por: Kuzuu, Kento, et al.
Publicado: (2023)

Comparison of the diagnostic performance of NBI, Laser-BLI and LED-BLI: a randomized controlled noninferiority trial
por: Higurashi, Takuma, et al.
Publicado: (2022)

Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis
por: MAKIZAKI, Yutaka, et al.
Publicado: (2018)

Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD
por: Nogami, Asako, et al.
Publicado: (2022)

Assessment of colonic contents in patients with chronic constipation using MRI
por: Inoh, Yumi, et al.
Publicado: (2018)

Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease
por: Kessoku, Takaomi, et al.
Publicado: (2020)

Proteomic Profiling of Bifidobacterium bifidum S17 Cultivated Under In Vitro Conditions
por: Wei, Xiao, et al.
Publicado: (2016)

Bifidobacterium bifidum PRL2010 alleviates intestinal ischemia/reperfusion injury
por: Duranti, Sabrina, et al.
Publicado: (2018)

Bifidobacterium bifidum: A Key Member of the Early Human Gut Microbiota
por: Turroni, Francesca, et al.
Publicado: (2019)

Risk factors for post-colorectal endoscopic submucosal dissection (ESD) coagulation syndrome: a multicenter, prospective, observational study
por: Arimoto, Jun, et al.
Publicado: (2018)

Corrigendum: Alleviation of low-fiber diet-induced constipation by probiotic Bifidobacterium bifidum G9-1 is based on correction of gut microbiota dysbiosis
Publicado: (2021)

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease
por: Iwaki, Michihiro, et al.
Publicado: (2023)

Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis
por: Wang, Linlin, et al.
Publicado: (2021)

Immune Response to Bifidobacterium bifidum Strains Support Treg/Th17 Plasticity
por: López, Patricia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_f5aqk9e8um1m8lgtljoo7i2nri